Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of participants, overall and by calendar year of ART initiation (n = 9997)

From: Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada

  Period 1 Period 2 Period 3 Overall
(2000–2003) (2004–2007) (2008–2012) (2000–2012)
n = 2381 n = 3058 n = 4558 n = 9997
(%) (%) (%) (%)
Baseline age     
18–34 693 (29.1) 791 (25.9) 1459 (32.0) 2943 (29.4)
35–44 1034 (43.4) 1297 (42.4) 1518 (33.3) 3849 (38.5)
45–54 481 (20.2) 718 (23.5) 1145 (25.1) 2344 (23.4)
55+ 173 (7.3) 252 (8.2) 436 (9.6) 861 (8.6)
Sex     
Female 480 (20.2) 591 (19.3) 760 (16.7) 1831 (18.3)
Male 1901 (79.8) 2467 (80.7) 3798 (8303) 8166 (81.7)
History of IDUa     
Yes 592 (31.0) 719 (29.5) 830 (23.7) 2141 (27.3)
No 1315 (69.0) 1721 (70.5) 2666 (76.3) 5702 (72.7)
Aboriginal ancestryb     
Yes 150 (10.6) 151 (9.7) 166 (9.4) 467 (9.8)
No 1266 (89.4) 1410 (90.3) 1599 (90.6) 4275 (90.2)
CD4 cell count (cells/μL)     
<350 2024 (85.0) 2679 (87.6) 2986 (65.5) 7689 (76.9)
≥350 357 (15.0) 379 (12.4) 1572 (34.5) 2308 (23.1)
  1. Analyses restricted to those with non-missing data
  2. IDU injection drug use
  3. an = 7843
  4. bn = 4742